North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Source (In-house, Outsourcing), By Product, By End Use (Independent Pharmacies, Long Term Care Facility), By Country, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
North America Unit Dose Manufacturing Market Growth & Trends
The North America unit dose manufacturing market size is expected to reach USD 21.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.
Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.
Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.
However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.
North America Unit Dose Manufacturing Market Report Highlights
North America Unit Dose Manufacturing Market Growth & Trends
The North America unit dose manufacturing market size is expected to reach USD 21.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.
Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.
Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.
However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.
North America Unit Dose Manufacturing Market Report Highlights
- The outsourcing segment dominated the market and accounted for the largest revenue share of 59.6% in 2020. Unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules
- The solid unit dose segment held 49.1% of the revenue share in 2020. In 2018, oral solid dosage medicines accounted for 53% of all new pharmaceuticals approved by the FDA
- The independent pharmacies segment dominated the market and accounted for the largest revenue share of 34.1% in 2020
- The hospital segment held the second-largest revenue share in 2020. The segment is estimated to become 3.5 times of itself by 2028
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1: Understanding market dynamics
1.8.2 Objective - 2: Understanding market estimates and forecasts
1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increased Adoption of Unit Doses
3.2.1.2 Benefits of manufacturing unit doses over repackaging
3.2.1.3 Flourishing pharmaceutical industry
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges associated with the adoption of manufactured unit doses
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 North America Unit Dose Manufacturing: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
CHAPTER 4 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: SOURCING SEGMENT ANALYSIS
4.1 North America Unit Dose Manufacturing Market: Sourcing Market Share Analysis, 2020 & 2028
4.2 In-House
4.2.1 In House Market, 2016 - 2028 (USD Million)
4.3 Outsource
4.3.1 Outsource Market, 2016 - 2028 (USD Million)
CHAPTER 5 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: PRODUCT SEGMENT ANALYSIS
5.1 North America Unit Dose Manufacturing Market: Product Market Share Analysis, 2020 & 2028
5.2 Liquid unit dose
5.2.1 Liquid Unit Dose Manufacturing market, 2016 - 2028 (USD Million)
5.3 Solid unit dose
5.3.1 Solid unit dose Manufacturing market, 2016 - 2028 (USD Million)
5.4 Others
5.4.1 Others market, 2016 - 2028 (USD Million)
CHAPTER 6 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: END-USE SEGMENT ANALYSIS
6.1 North America Unit Dose Manufacturing Market: End-use Market Share Analysis, 2020 & 2028
6.2 Independent Pharmacies
6.2.1 Independent Pharmacies Market, 2016 - 2028 (USD Million)
6.2 Long Term Care Facility
6.2.2. Long Term Care Facility Market, 2016 - 2028 (USD Million)
6.3 Hospitals
6.3.2. Hospitals Market, 2016 - 2028 (USD Million)
6.4 Others
6.4.2. Others Market, 2016 - 2028 (USD Million)
CHAPTER 7 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: COUNTRY ANALYSIS
7.1 North America Unit Dose Manufacturing Market: Country Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Catalent Inc
8.1.1 Company Overview
8.1.2 Service Benchmarking
8.1.3 Financial Performance
8.1.4 Strategic Intiatives
8.2 Unither Pharmaceuticals
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Service Benchmarking
8.2.5 Strategic Initiatives
8.3 ThermoFisher Pantheon
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.2 Service Benchmarking
8.3.3 Strategic Initiatives
8.4 Corden Pharma.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Service Benchmarking
8.5 Mikart
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Service Benchmarking
8.6 Tape Mark
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Service Benchmarking
8.7 Renaissance Lakewood LLC
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Service Benchmarking
8.7.4 Strategic Initiatives
8.8 Medical Packaging Inc
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Service Benchmarking
8.8.4 Strategic Initiatives
8.9 American Health Packaging
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Service Benchmarking
8.9.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1: Understanding market dynamics
1.8.2 Objective - 2: Understanding market estimates and forecasts
1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increased Adoption of Unit Doses
3.2.1.2 Benefits of manufacturing unit doses over repackaging
3.2.1.3 Flourishing pharmaceutical industry
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges associated with the adoption of manufactured unit doses
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 North America Unit Dose Manufacturing: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
CHAPTER 4 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: SOURCING SEGMENT ANALYSIS
4.1 North America Unit Dose Manufacturing Market: Sourcing Market Share Analysis, 2020 & 2028
4.2 In-House
4.2.1 In House Market, 2016 - 2028 (USD Million)
4.3 Outsource
4.3.1 Outsource Market, 2016 - 2028 (USD Million)
CHAPTER 5 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: PRODUCT SEGMENT ANALYSIS
5.1 North America Unit Dose Manufacturing Market: Product Market Share Analysis, 2020 & 2028
5.2 Liquid unit dose
5.2.1 Liquid Unit Dose Manufacturing market, 2016 - 2028 (USD Million)
5.3 Solid unit dose
5.3.1 Solid unit dose Manufacturing market, 2016 - 2028 (USD Million)
5.4 Others
5.4.1 Others market, 2016 - 2028 (USD Million)
CHAPTER 6 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: END-USE SEGMENT ANALYSIS
6.1 North America Unit Dose Manufacturing Market: End-use Market Share Analysis, 2020 & 2028
6.2 Independent Pharmacies
6.2.1 Independent Pharmacies Market, 2016 - 2028 (USD Million)
6.2 Long Term Care Facility
6.2.2. Long Term Care Facility Market, 2016 - 2028 (USD Million)
6.3 Hospitals
6.3.2. Hospitals Market, 2016 - 2028 (USD Million)
6.4 Others
6.4.2. Others Market, 2016 - 2028 (USD Million)
CHAPTER 7 NORTH AMERICA UNIT DOSE MANUFACTURING MARKET: COUNTRY ANALYSIS
7.1 North America Unit Dose Manufacturing Market: Country Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Catalent Inc
8.1.1 Company Overview
8.1.2 Service Benchmarking
8.1.3 Financial Performance
8.1.4 Strategic Intiatives
8.2 Unither Pharmaceuticals
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Service Benchmarking
8.2.5 Strategic Initiatives
8.3 ThermoFisher Pantheon
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.2 Service Benchmarking
8.3.3 Strategic Initiatives
8.4 Corden Pharma.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Service Benchmarking
8.5 Mikart
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Service Benchmarking
8.6 Tape Mark
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Service Benchmarking
8.7 Renaissance Lakewood LLC
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Service Benchmarking
8.7.4 Strategic Initiatives
8.8 Medical Packaging Inc
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Service Benchmarking
8.8.4 Strategic Initiatives
8.9 American Health Packaging
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Service Benchmarking
8.9.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 4 North America Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 5 North America Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 6 U.S. Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 7 U.S. Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 8 U.S. Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 9 Canada Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 10 Canada Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 11 Canada Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 4 North America Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 5 North America Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 6 U.S. Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 7 U.S. Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 8 U.S. Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 9 Canada Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 10 Canada Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 11 Canada Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America unit dose manufacturing market snapshot (2020)
Fig. 9 North America unit dose manufacturing market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 North America unit dose manufacturing market sourcing outlook: Segment dashboard
Fig. 16 North America unit dose manufacturing market: Sourcing movement analysis
Fig. 17 In-house market, 2016 - 2028 (USD Million)
Fig. 18 Outsourcing market, 2016 - 2028 (USD Million)
Fig. 19 North America unit dose manufacturing market product outlook: Segment dashboard
Fig. 20 North America unit dose manufacturing market: Product movement analysis
Fig. 21 Liquid unit dose market, 2016 - 2028 (USD Million)
Fig. 22 Solid unit dose market, 2016 - 2028 (USD Million)
Fig. 23 Others market, 2016 - 2028 (USD Million)
Fig. 24 North America unit dose manufacturing market end-use outlook: Segment dashboard
Fig. 25 North America unit dose manufacturing market: end-use movement analysis
Fig. 26 Independent Pharmacies market, 2016-2028 (USD Million)
Fig. 27 Long term facility market, 2016 - 2028 (USD Million)
Fig. 28 Hospitals market, 2016 - 2028 (USD Million)
Fig. 29 Others market, 2016 - 2028 (USD Million)
Fig. 30 Others market, 2016 - 2028 (USD Million)
Fig. 31 Regional market: Key takeaways
Fig. 32 Regional outlook, 2020 & 2028
Fig. 33 North America market, 2016 - 2028 (USD Million)
Fig. 34 U.S. market, 2016 - 2028 (USD Million)
Fig. 35 Canada market, 2016 - 2028 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America unit dose manufacturing market snapshot (2020)
Fig. 9 North America unit dose manufacturing market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 North America unit dose manufacturing market sourcing outlook: Segment dashboard
Fig. 16 North America unit dose manufacturing market: Sourcing movement analysis
Fig. 17 In-house market, 2016 - 2028 (USD Million)
Fig. 18 Outsourcing market, 2016 - 2028 (USD Million)
Fig. 19 North America unit dose manufacturing market product outlook: Segment dashboard
Fig. 20 North America unit dose manufacturing market: Product movement analysis
Fig. 21 Liquid unit dose market, 2016 - 2028 (USD Million)
Fig. 22 Solid unit dose market, 2016 - 2028 (USD Million)
Fig. 23 Others market, 2016 - 2028 (USD Million)
Fig. 24 North America unit dose manufacturing market end-use outlook: Segment dashboard
Fig. 25 North America unit dose manufacturing market: end-use movement analysis
Fig. 26 Independent Pharmacies market, 2016-2028 (USD Million)
Fig. 27 Long term facility market, 2016 - 2028 (USD Million)
Fig. 28 Hospitals market, 2016 - 2028 (USD Million)
Fig. 29 Others market, 2016 - 2028 (USD Million)
Fig. 30 Others market, 2016 - 2028 (USD Million)
Fig. 31 Regional market: Key takeaways
Fig. 32 Regional outlook, 2020 & 2028
Fig. 33 North America market, 2016 - 2028 (USD Million)
Fig. 34 U.S. market, 2016 - 2028 (USD Million)
Fig. 35 Canada market, 2016 - 2028 (USD Million)
